Willi Cawello

Title: Willi Cawello: Innovator in Transdermal Therapeutics

Introduction

Willi Cawello is a notable inventor based in Monheim, Germany. He has made significant contributions to the field of transdermal drug delivery systems. With a focus on innovative therapeutic solutions, Cawello holds 2 patents that address critical medical needs.

Latest Patents

Cawello's latest patents include a multi-day patch for the transdermal administration of rotigotine. This invention relates to a transdermal therapeutic system that comprises a backing layer, a solvent-based self-adhesive matrix layer containing rotigotine as the active ingredient, and a release liner. The self-adhesive matrix layer is designed to allow for the transdermal administration of therapeutically effective amounts of rotigotine for at least three days. This system is particularly beneficial for patients suffering from Parkinson's disease, depression, fibromyalgia, and other related conditions. Another significant patent is a daily formulation of lacosamide, which is a modified release formulation suitable for once-daily administration.

Career Highlights

Throughout his career, Cawello has worked with prominent companies in the pharmaceutical industry, including UCB Pharma GmbH and LTS Lohmann Therapie-Systeme AG. His work has focused on developing innovative drug delivery systems that enhance patient care and treatment efficacy.

Collaborations

Cawello has collaborated with several professionals in his field, including Martin Alexander Schubert and Aurelia Lappert. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Willi Cawello is a distinguished inventor whose work in transdermal therapeutics has the potential to improve the quality of life for many patients. His innovative patents reflect his commitment to advancing medical technology and addressing critical health challenges.